By Ben Coxworth August 22, 2025 Facebook Twitter LinkedIn Reddit Email Whereas intravenous drips (pictured) typically last a few hours, the new technology would allow the same dosage of medication to be injected in a matter of seconds Depositphotos View 2 Images It’s a sad and inconvenient fact that many drugs have to be administered in […]
New meds-prepping process could make IV drug drips a thing of the past Read More »
by Lorena Infante Lara, Vanderbilt University edited by Lisa Lock, reviewed by Robert Egan Multimodal imaging of hyperreflective foci and ectopic RPE cells. Arrows in panels A and B show foci as observed through OCT and bright-field microscopy. Panels C–E show native RPE cells, identified by the yellow arrows, and migrating RPEs, identified by cyan arrows. Credit: Proceedings
Q&A: Altered lipid metabolism as a possible culprit in age-related vision loss Read More »
by Peter MacCallum Cancer Centre edited by Lisa Lock, reviewed by Robert Egan Victorian brain cancer researchers have used an innovative process to learn how a new drug suppresses tumour activity and provides hope to patients with low-grade gliomas (LGG). It’s the first clinical trial to be conducted through the pioneering Brain Perioperative platform, or “BrainPOP.” Credit: Peter
Clinical trial reveals unprecedented insights into brain cancer treatment Read More »
by European Alliance of Associations for Rheumatology (EULAR) edited by Lisa Lock, reviewed by Andrew Zinin Credit: Unsplash/CC0 Public Domain Systemic lupus erythematosus (SLE) is a complex and potentially life-threatening autoimmune disease. Part of the complexity stems from how it can differ from person to person—giving rise to marked heterogeneity in not only manifestations, but also in
New recommendations on core datasets to be used in systemic lupus erythematosus care Read More »
by Case Western Reserve University edited by Gaby Clark, reviewed by Robert Egan Credit: Pixabay/CC0 Public Domain A team of scientists led by the Institute for Glial Sciences (IGS) at Case Western Reserve University’s School of Medicine has discovered a built-in “brake” that controls when key brain cells mature. In multiple sclerosis (MS), this brake appears to
Molecular ‘brake’ in brain development could hold key to treating multiple sclerosis Read More »
by NYU Langone Health edited by Sadie Harley, reviewed by Robert Egan Credit: Pixabay/CC0 Public Domain Antiseizure medications help the majority of people with focal epilepsy, a common form of the neurological disorder. Yet most will still have episodes for at least a year after their treatment begins, until their doctors can find the right drug and dosage
Download PDF Copy Reviewed KAIST (Korea Advanced Institute of Science and Technology)Aug 25 2025 Major depressive disorder (MDD) is one of the most common psychiatric illnesses worldwide, but its molecular causes have still not been clearly identified. A domestic research team has discovered that depression may not simply be caused by neuronal damage, but can also arise
New molecular mechanism offers hope for treating depression in the elderly Read More »
Download PDF Copy Reviewed University of GenevaAug 25 2025 Colorectal cancer is the second leading cause of cancer death worldwide. If detected early, it can be efficiently treated, but the cost and discomfort of colonoscopies – the main diagnostic method currently in use – often result in delayed diagnosis. Using machine learning algorithms, a team
Gut bacteria provide key to identifying colorectal cancer from stool samples Read More »
Peer-Reviewed Publication Mass General Brigham Researchers found dietary changes may help improve cognitive health and stave off dementia A new study led by investigators from Mass General Brigham, Harvard T.H. Chan School of Public Health, and the Broad Institute of MIT and Harvard suggests that a Mediterranean-style diet may help reduce dementia risk. The study, published
Mediterranean diet may offset genetic risk of Alzheimer’s – Read More »
by European Association for the Study of Diabetes edited by Sadie Harley, reviewed by Robert Egan Credit: Unsplash/CC0 Public Domain The first study of its kind to compare cardiovascular risk in type 1 diabetes (T1D) and type 2 diabetes (T2D) in both men and women shows that younger men with T2D have worse mortality and cardiovascular disease
Study compares cardiovascular disease risk in type 1 and 2 diabetes in men and women Read More »
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866